https://orcid.org/0000-0003-2841-7089
Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Eric Duverger, Guillaume Herlem & Fabien Picaud. (2023) Nanovectorization of Ivermectin to avoid overdose of drugs. Journal of Biomolecular Structure and Dynamics 41:10, pages 4272-4285.
Read now
Read now
Nada A Ashour, Ayman Abo Elmaaty, Amany A Sarhan, Eslam B Elkaeed, Ahmed M Moussa, Ibrahim Ali Erfan & Ahmed A Al-Karmalawy. (2022) A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval. Drug Design, Development and Therapy 16, pages 685-715.
Read now
Read now
Shubham Mule, Ajit Singh, Khaled Greish, Amirhossein Sahebkar, Prashant Kesharwani & Rahul Shukla. (2022) Drug repurposing strategies and key challenges for COVID-19 management. Journal of Drug Targeting 30:4, pages 413-429.
Read now
Read now
O.V. Tinkov, V.Y. Grigorev & L.D. Grigoreva. (2021) QSAR analysis of the acute toxicity of avermectins towards Tetrahymena pyriformis. SAR and QSAR in Environmental Research 32:7, pages 541-571.
Read now
Read now
Pravin Shende, Bhakti Khanolkar & R.S. Gaud. (2021) Drug repurposing: new strategies for addressing COVID-19 outbreak. Expert Review of Anti-infective Therapy 19:6, pages 689-706.
Read now
Read now
Radostina Alexandrova, Pencho Beykov, Dobrin Vassilev, Marko Jukić & Črtomir Podlipnik. (2021) The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19. Biotechnology & Biotechnological Equipment 35:1, pages 74-102.
Read now
Read now
Articles from other publishers (59)
Shaibu Oricha Bello, Mustapha Umar Imam, Muhammad Bashir Bello, Abdulmajeed Yunusa, Adamu Ahmed Adamu, Abdulmalik Shuaibu, Ehimario Uche Igumbor, Zaiyad Garba Habib, Mustapha Ayodele Popoola, Chinwe Lucia Ochu, Aishatu Yahaya Bello, Yusuf Yahaya Deeni & Ifeoma Okoye. (2023) Erythromycin, retapamulin, pyridoxine, folic acid, and ivermectin inhibit cytopathic effect, papain-like protease, and MPRO enzymes of SARS-CoV-2. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Vanyo Mitev. (2023) Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib. Pharmacia 70:4, pages 1177-1193.
Crossref
Crossref
Hari Madhav, Mohammad Rehan, Nasimul Hoda & Ehtesham Jameel. 2023. Chemistry and Biological Activities of Ivermectin. Chemistry and Biological Activities of Ivermectin
47
68
.
Reyhaneh Rasizadeh, Parisa Shiri Aghbash, Javid Sadri Nahand, Taher Entezari-Maleki & Hossein Bannazadeh Baghi. (2023) SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs. Virology Journal 20:1.
Crossref
Crossref
Ammar Khalo Abass Kasho, Javid Sadri Nahand, Arash Salmaninejad, Hamed Mirzaei, Mohsen Moghoofei, Ahad Bazmani, Parisa Shiri Aghbash, Reyhaneh Rasizadeh, Nader Farsad-Akhtar & Hossein Bannazadeh Baghi. (2023) PBMC MicroRNAs: Promising Biomarkers for the Differential Diagnosis of COVID-19 Patients with Abnormal Coagulation Indices. Current Microbiology 80:8.
Crossref
Crossref
Elisa Souza Vaz, Sandra Valeria Vassiliades, Jeanine Giarolla, Michelle Carneiro Polli & Roberto Parise-Filho. (2023) Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies. European Journal of Clinical Pharmacology 79:6, pages 723-751.
Crossref
Crossref
Tatsuhiko Wada, Makoto Hibino, Hiromi Aono, Shunsuke Kyoda, Yosuke Iwadate, Eri Shishido, Keisuke Ikeda, Nana Kinoshita, Yasuki Matsuda, Sakiko Otani, Ryo Kameda, Kenta Matoba, Miwa Nonaka, Mika Maeda, Yuji Kumagai, Junya Ako, Masayoshi Shichiri, Katsuhiko Naoki, Masato Katagiri, Masashi Takaso, Masatsugu Iwamura, Kazuhiko Katayama, Takeshi Miyatsuka, Yasushi Orihashi & Kunihiro Yamaoka. (2023) Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial. Frontiers in Medicine 10.
Crossref
Crossref
Kaushick Mishra, Asis Manna, Ram Mohan Roy, Yogiraj Roy & Koushik Choudhury. (2023) Therapeutic Efficacy of Ivermectin in Novel Coronavirus Disease-2019 Patient Admitted at the Ward of a Tertiary Care Hospital: A Retrospective Study. Indian Journal of Respiratory Care 12:1, pages 3-7.
Crossref
Crossref
Pankaj Musyuni, Ruchika Sharma & Geeta Aggarwal. (2023) Optimizing drug discovery: An opportunity and application with reverse translational research. Health Sciences Review 6, pages 100074.
Crossref
Crossref
Swati Srivastava, Iti Garg, Yamini Singh, Ramesh Meena, Nilanjana Ghosh, Babita Kumari, Vinay Kumar, Malleswara Rao Eslavath, Sayar Singh, Vikas Dogra, Mona Bargotya, Sonali Bhattar, Utkarsh Gupta, Shruti Jain, Javid Hussain, Rajeev Varshney & Lilly Ganju. (2023) Evaluation of altered miRNA expression pattern to predict COVID-19 severity. Heliyon 9:2, pages e13388.
Crossref
Crossref
Farshad M. Shirazi, Roya Mirzaei, Samaneh Nakhaee, Amir Nejatian, Shokouh Ghafari & Omid Mehrpour. (2022) Repurposing the drug, ivermectin, in COVID-19: toxicological points of view. European Journal of Medical Research 27:1.
Crossref
Crossref
Ayman M. El-Ashkar, Soheir Mahmoud, Hoda Sabry, Nevine Guirguis, Wafaa El Komi, Eman Ali, Tarek Abu Shousha & Hagar F. Abdelmksoud. (2022) Nitazoxanide, Ivermectin, and Artemether effects against cryptosporidiosis in diabetic mice: parasitological, histopathological, and chemical studies. Journal of Parasitic Diseases 46:4, pages 1070-1079.
Crossref
Crossref
Satyajit Mohapatra, Preethika Ananda & Saswati Tripathy. (2022) Pharmacological consideration of COVID-19 infection and vaccines in pregnancy. Journal of the Chinese Medical Association 85:5, pages 537-542.
Crossref
Crossref
Wei Shen Ho, Ruirui Zhang, Yeong Lan Tan & Christina Li Lin Chai. (2022) COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?. Pharmacological Research 179, pages 106201.
Crossref
Crossref
Rajan Ravichandran, Surapaneni Krishna Mohan, Suresh Kumar Sukumaran, Devakumar Kamaraj, Sumetha Suga Daivasuga, Samson Oliver Abraham Samuel Ravi, Sivakumar Vijayaraghavalu & Ramarathnam Krishna Kumar. (2022) An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients. Scientific Reports 12:1.
Crossref
Crossref
Steven Chee Loon Lim, Chee Peng Hor, Kim Heng Tay, Anilawati Mat Jelani, Wen Hao Tan, Hong Bee Ker, Ting Soo Chow, Masliza Zaid, Wee Kooi Cheah, Han Hua Lim, Khairil Erwan Khalid, Joo Thye Cheng, Hazfadzila Mohd Unit, Noralfazita An, Azraai Bahari Nasruddin, Lee Lee Low, Song Weng Ryan Khoo, Jia Hui Loh, Nor Zaila Zaidan, Suhaila Ab Wahab, Li Herng Song, Hui Moon Koh, Teck Long King, Nai Ming Lai, Suresh Kumar Chidambaram, Kalaiarasu M. Peariasamy, Wen Yea Hwong, Ee Vien Low, Mohan Dass Pathmanathan, Muhammad Luqman Hamzah, Yew Chung Chan, James Yau Hon Voo, Chun Fei Yap, Yon Quan Chan, Lee Kuen Vun, Kent Kian Keong Kong, Yi Fang Lim, Yee Jie Teoh, Ammar Rashidi Abdullah, Anitha Ramadas, Chee Loon Leong, Noor Hidayu Wahab, Nadiah Ismail, Ismaliza Ismail, Tung Meng Lee, Pei Jie Khoo, Sook Hui Phua, Prethivan Pillai Gopalakrishnan, Sangeetha Jaya Selan, Iswaran Ampalakan, Jen Fai Khuan, Wan Nur Farra’Ain Abdul Rashid, Siti Sha’ada Zakaria, Kalaiarasan Gemini, Haslina Burahan, Thaanveer Singh Santokh Singh, Noorfarzlina Jaafar, Nor Atikah Mohd Shukri, Syaza Izhar Hisham, Sheng Hao Teow, Chit Yeh Lim, Shageetha Rajantran, Siti Izzatul Annis Kamaruddin, Izarin Izmir Izhar, Nur Syuhada Mohd Mustapha, Zulkefli Mohamad, Seri Rabiatul Nur Abu Salim, Delarina Frimawati Othman Andu, Nurnadiah Kamarudin, Karamjit Kaur Sarban Singh, Eek Poei Tay, Siti Hir Huraizah Md Tahir, Shalini Vijayasingham, Yik Zhi Kum, Peter Andrew Natarajan, Yih Harng Soh, Syed Omar Farouk Syed Alwi, Hemaarubeni Murugan, Chuan Huan Chuah, Shin Wuei Tan, Kar Nim Leong, Peng Shyan Wong, Wendy Tyng Tyng Chen, Ru Shing Ng, Yen Li Lim, Farah Nadiah Bidin, Mann Leon Chin, Han Lin Guan, Mohd Hafiz Mohamad Rasli, Rafidah Abdullah, Mohd Akmal Jamaludin, Nabilah Mohd Shohaime, Syafiqah Mohd Mansor, Ruhaizad Rasliza, Lisa Mohamed Nor, Kah Mean Thong, Balasurindiran Muniandy, Pamela Varn Teing Saw, Kah Shuen Thong, Kee Cheong Wong, V. Rubini Nair Muthi, Qhairyl Iylman Ahmad Shanizza, Lavanya Jeevaraj, Ee Lin Chew, Poh Ching Huang, Jasmine Retnasamy, Philip Rajan Devesahayam, Mei San Lim, Thilagavathi Thanusia Viswanathan, Muhammad Syafiq Mahamad Azazis, Gregory Domnic, Muhammad Fursanallah Tengku, Jeanette Qiu Yi Wong, Xin Hui Choo, Ambika Nair Prabhaharan, Nur Shakirah Zaharudin, Asma Usa’diyah Abu Bakar Sayuti, Nabilah Abdul Wahid, Nurul Hasanah Saat, Nurul Huda Othman, Aisyah Ahmad Zubaidi, Nurul Miza Shasheiha Abdul Mutalib, Viknesh Dev Lekh Raj Sharma, Daleni Gunaraj, Muhammad Na'imuddin'alim Hanafi, Nurul Atiqah Embok Ungah, Muhammad Ariffadilah Mohd Zahari, Chun Lian Chaw, Jennifer Arokisamy, Puteri Amira Mohd Hassan, Ainun Jariah Ayub, Azrin Nurfarahin Zainal Abidin, Khai Sin Choong, Lee Rhui Teoh, Huan Yean Kang, Kesavathy Krishnan, Peacchaima Purusothman, Mohamad Izwan Zainol, Mei Mei Tew, Mohd Fyzal Bahrudin, Kah Chuan Lim, Sharmila Mohd Nadzir, Lavanya Narayanan, Amira Naziffa Shamsuddin, Kok Tong Tan, Shaharudeen Kamaludeen, Nur Munirah Ibrahim, Pearly Kim Aik Sim, Irdina Aminuddi, Raja Nurulain Raja Nahar Putra, Lin Ye Yah, Boon Seng Liew, Tharmini Ravi, Syarifah Nurul Ain Syed Badaruddin, Nur Suriana Mah Hassan, Zulaika Roslan, Reshaini Nadarajan, Jian-Gang Ang, Minalosani Arumugam, Kin Wei Chua, Calvin Gim Seong Ooi, Siew Huang Lee, Way Ti Ooi, Xing Yi Tang, Kunaraj Perumalu, Muhammad Hazazi Razali, Mohamad Shamirul Afiq Murat, Nor Syahirah Hamdan, Muhammad Syafiq Hamidi, Amalina Anuar, Wei Chern Ang, Chee Kong Wong, Irma Liyana Mushaddik, Shafarul Halimi Mohamed, Raja Ahmad Reza Raja Lope Ahmad, Wan Mohd Khairul Wan Zainudin, Ahmad Fikhri Mohd Zin, Sze Kye Teoh, Mohd Yusran Yusoff, Siti Norizan Abdul Rani, Mazilah Ab Rahman, Maizatul Akmal Mohd Noor, Tuan Norhafiza Tuan Mat, Mohd Khairi Othman, Mohammad Sayed Sahul Hamid Gani, Ching Zin Ngua, Andrew Kean Wei Chang, Zhun Han Wong, Andy Tze Yang Ko, Su Fui Thung, Xun Ting Tiong, Hock Hin Chua, Kiam Seong Goh, Shanthini Muthusamy, Wai Yang Loo, Thamarai Supramaniam, Rakesh Lingam, Logadharshini Chandra Kumar, Siew Theng Chun, Dariel R Selvarajah, Darshinnee Mohan Raja, One Ling Low, Prathiv Supparmaniam, Husna Ad Suhadak, Boon Cong Beh, Yi Lin Lee, Cheng Lee Ooi, Khairul Nisa' Ishak, Rozila Harun, Soon Leng Lee, Kok Soon Lee, Ji Ken Ow, Neerusha Kaisbain, Caryn Jia Wern Leong, Yun Lee Chee, Keng Long Teh, Kam Veng Chan, Kee Tat Lee, E Jinq Wong, Ibtisam Ismail, Mohd Azri Mohd Suan, Ahmad Lutfi Mohamed Yusoff, Tuan Muhd Fairuz Tuan Ismail @Tuan Manah, Khairul Azmi Ibrahim, Hazfadzila Mohd Unit, Norsima Nazifah Sidek & Noraini Seman. (2022) Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities. JAMA Internal Medicine 182:4, pages 426.
Crossref
Crossref
Maral Aminpour, Marco Cannariato, Jordane Preto, M. Ehsan Safaeeardebili, Alexia Moracchiato, Domiziano Doria, Francesca Donato, Eric Adriano Zizzi, Marco Agostino Deriu, David E. Scheim, Alessandro D. Santin & Jack Adam Tuszynski. (2022) In Silico Analysis of the Multi-Targeted Mode of Action of Ivermectin and Related Compounds. Computation 10:4, pages 51.
Crossref
Crossref
Jose Lenin Beltran Gonzalez, Mario González Gámez, Emanuel Antonio Mendoza Enciso, Ramiro Josue Esparza Maldonado, Daniel Hernández Palacios, Samuel Dueñas Campos, Itzel Ovalle Robles, Mariana Jocelyn Macías Guzmán, Andrea Lucia García Díaz, César Mauricio Gutiérrez Peña, Lucila Martinez Medina, Victor Antonio Monroy Colin & Jose Manuel Arreola Guerra. (2022) Efficacy and Safety of Ivermectin and Hydroxychloroquine in Patients with Severe COVID-19: A Randomized Controlled Trial. Infectious Disease Reports 14:2, pages 160-168.
Crossref
Crossref
Büşra Ünlü, Rahime Simsek, Selinay Başak Erdemli Köse, Anıl Yirün & Pinar Erkekoglu. (2022) Neurological Effects of SARS-CoV-2 and Neurotoxicity of Antiviral Drugs
Against COVID-19. Mini-Reviews in Medicinal Chemistry 22:2, pages 213-231.
Crossref
Crossref
Nilima Dinesh Kumar, Bram M. ter Ellen, Ellen M. Bouma, Berit Troost, Denise P. I. van de Pol, Heidi H. van der Ende-Metselaar, Djoke van Gosliga, Leonie Apperloo, Orestes A. Carpaij, Maarten van den Berge, Martijn C. Nawijn, Ymkje Stienstra, Izabela A. Rodenhuis-Zybert & Jolanda M. Smit. (2022) Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells. Antimicrobial Agents and Chemotherapy 66:1.
Crossref
Crossref
Sireethorn Nimitvilai, Yupin Suputtamongkol, Ussanee Poolvivatchaikarn, Dechatorn Rassamekulthana, Nuttawut Rongkiettechakorn, Anek Mungaomklang, Susan Assanasaen, Ekkarat Wongsawat, Chompunuch Boonarkart & Waritta Sawaengdee. (2022) A randomized controlled trial of combined ivermectin and zinc sulfate versus combined hydroxychloroquine, darunavir/ritonavir, and zinc sulfate among adult patients with asymptomatic or mild coronavirus-19 infection. Journal of Global Infectious Diseases 14:2, pages 69.
Crossref
Crossref
Poppy O. Smith, Peiqin Jin & Khondaker Miraz Rahman. (2022) Strategies for drug repurposing against coronavirus targets. Current Research in Pharmacology and Drug Discovery 3, pages 100072.
Crossref
Crossref
Lalit Mohan Nainwal & Suman. 2022. Coronavirus Drug Discovery. Coronavirus Drug Discovery
249
264
.
Jigna Patel. 2022. Principles in Nursing Practice in the Era of COVID-19. Principles in Nursing Practice in the Era of COVID-19
67
96
.
Halie M. Rando, Nils Wellhausen, Soumita Ghosh, Alexandra J. Lee, Anna Ada Dattoli, Fengling Hu, James Brian Byrd, Diane N. Rafizadeh, Ronan Lordan, Yanjun Qi, Yuchen Sun, Christian Brueffer, Jeffrey M. Field, Marouen Ben Guebila, Nafisa M. Jadavji, Ashwin N. Skelly, Bharath Ramsundar, Jinhui Wang, Rishi Raj Goel, YoSon Park, Simina M. Boca, Anthony Gitter & Casey S. Greene. (2021) Identification and Development of Therapeutics for COVID-19. mSystems 6:6.
Crossref
Crossref
Elmoubasher A. Farag, Md Mazharul Islam, Khalid Enan, Abdel-Rahim M. El-Hussein, Devendra Bansal & Mohamed Haroun. (2021) SARS-CoV-2 at the human-animal interface: A review. Heliyon 7:12, pages e08496.
Crossref
Crossref
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Govindasamy Agoramoorthy & Sang-Soo Lee. (2021) The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies. Frontiers in Pharmacology 12.
Crossref
Crossref
Mark J Siedner. (2021) Ivermectin for the Treatment of COVID-19 Disease: Too Good to Pass Up or Too Good to Be True?. Open Forum Infectious Diseases 8:11.
Crossref
Crossref
Yash Gupta, Dawid Maciorowski, Samantha E. Zak, Krysten A. Jones, Rahul S. Kathayat, Saara-Anne Azizi, Raman Mathur, Catherine M Pearce, David J. Ilc, Hamza Husein, Andrew S. Herbert, Ajay Bharti, Brijesh Rathi, Ravi Durvasula, Daniel P. Becker, Bryan C. Dickinson, John M. Dye & Prakasha Kempaiah. (2021) Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays. Methods 195, pages 57-71.
Crossref
Crossref
Tean Zaheer, Kaushik Pal, Rao Zahid Abbas & María del Pilar Rodríguez Torres. (2021) COVID-19 and Ivermectin: Potential threats associated with human use. Journal of Molecular Structure 1243, pages 130808.
Crossref
Crossref
Lenin González-Paz, María Laura Hurtado-León, Carla Lossada, Francelys V. Fernández-Materán, Joan Vera-Villalobos, Marcos Loroño, J.L. Paz, Laura Jeffreys & Ysaias J. Alvarado. (2021) Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: A computational and biophysical approach. Biophysical Chemistry 278, pages 106677.
Crossref
Crossref
Suzan M. Mansour, Rehab N. Shamma, Kawkab A. Ahmed, Nirmeen A. Sabry, Gamal Esmat, Azza A. Mahmoud & Amr Maged. (2021) Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study. International Immunopharmacology 99, pages 108004.
Crossref
Crossref
Sherief Abd‐Elsalam, Rasha A. Noor, Rehab Badawi, Mai Khalaf, Eslam S. Esmail, Shaimaa Soliman, Mohamed S. Abd El Ghafar, Mohamed Elbahnasawy, Ehab F. Moustafa, Sahar M. Hassany, Mohammed A. Medhat, Haidi Karam‐Allah Ramadan, Maii A. S. Eldeen, Mohamed Alboraie, Ahmed Cordie & Gamal Esmat. (2021) Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study. Journal of Medical Virology 93:10, pages 5833-5838.
Crossref
Crossref
Hao Ying, Mohsen Ebrahimi, Mona Keivan, Seyed Esmaeil Khoshnam, Sarvenaz Salahi & Maryam Farzaneh. (2021) miRNAs; a novel strategy for the treatment of COVID‐19. Cell Biology International 45:10, pages 2045-2053.
Crossref
Crossref
Al Hakim, Md. Mahbub Hasan, Mahmudul Hasan, Syed Mohammad Lokman, Kazi Faizul Azim, Topu Raihan, Parveen Afroz Chowdhury & Abul Kalam Azad. (2021) Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges. Frontiers in Microbiology 12.
Crossref
Crossref
Julien Sourimant, Megha Aggarwal & Richard K Plemper. (2021) Progress and pitfalls of a year of drug repurposing screens against COVID-19. Current Opinion in Virology 49, pages 183-193.
Crossref
Crossref
Larissa E van Eijk, Mathijs Binkhorst, Arno R Bourgonje, Annette K Offringa, Douwe J Mulder, Eelke M Bos, Nikola Kolundzic, Amaal E Abdulle, Peter HJ van der Voort, Marcel GM Olde Rikkert, Johannes G van der Hoeven, Wilfred FA den Dunnen, Jan‐Luuk Hillebrands & Harry van Goor. (2021)
COVID
‐19: immunopathology, pathophysiological mechanisms, and treatment options
. The Journal of Pathology 254:4, pages 307-331.
Crossref
Crossref
Harpinder Kaur, Nishant Shekhar, Saurabh Sharma, Phulen Sarma, Ajay Prakash & Bikash Medhi. (2021) Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes. Pharmacological Reports 73:3, pages 736-749.
Crossref
Crossref
Alessio Danilo Inchingolo, Gianna Dipalma, Angelo Michele Inchingolo, Giuseppina Malcangi, Luigi Santacroce, Maria Teresa D’Oria, Ciro Gargiulo Isacco, Ioana Roxana Bordea, Sebastian Candrea, Antonio Scarano, Benedetta Morandi, Massimo Del Fabbro, Marco Farronato, Gianluca Martino Tartaglia, Mario Giosuè Balzanelli, Andrea Ballini, Ludovica Nucci, Felice Lorusso, Silvio Taschieri & Francesco Inchingolo. (2021) The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants. Antioxidants 10:6, pages 881.
Crossref
Crossref
Alain Bousquet-Mélou, Anne Lespine, Jean-François Sutra, Isabelle Bargues & Pierre-Louis Toutain. (2021) A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients. Frontiers in Pharmacology 12.
Crossref
Crossref
Snejina Vassileva, Valeria Mateeva & Kossara Drenovska. (2021) Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?. Clinics in Dermatology 39:3, pages 430-445.
Crossref
Crossref
Jose Chacko & Muhammed Unais. (2022) Pharmacologic Treatment of COVID-19: Evidence-Based Update. Indian Journal of Respiratory Care 10:S1, pages S34-S38.
Crossref
Crossref
Eduardo López-Medina, Pío López, Isabel C. Hurtado, Diana M Dávalos, Oscar Ramirez, Ernesto Martínez, Jesus A. Díazgranados, José M. Oñate, Hector Chavarriaga, Sócrates Herrera, Beatriz Parra, Gerardo Libreros, Roberto Jaramillo, Ana C. Avendaño, Dilian F. Toro, Miyerlandi Torres, Maria C. Lesmes, Carlos A. Rios & Isabella Caicedo. (2021) Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19. JAMA 325:14, pages 1426.
Crossref
Crossref
Alessio Danilo Inchingolo, Angelo Michele Inchingolo, Ioana Roxana Bordea, Giuseppina Malcangi, Edit Xhajanka, Antonio Scarano, Felice Lorusso, Marco Farronato, Gianluca Martino Tartaglia, Ciro Gargiulo Isacco, Grazia Marinelli, Maria Teresa D’Oria, Denisa Hazballa, Luigi Santacroce, Andrea Ballini, Maria Contaldo, Francesco Inchingolo & Gianna Dipalma. (2021) SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention. Microorganisms 9:3, pages 525.
Crossref
Crossref
Srinivasa Reddy Bonam, Niranjan G. Kotla, Raghvendra A. Bohara, Yury Rochev, Thomas J. Webster & Jagadeesh Bayry. (2021) Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections. Nano Today 36, pages 101051.
Crossref
Crossref
E. Sallard, D. Belhadi, F.-X. Lescure, Y. Yazdanpanah & N. Peiffer-Smadja. (2021) Clinical trial protocols of repurposed prophylaxis for COVID-19: A review. Infectious Diseases Now 51:1, pages 7-13.
Crossref
Crossref
M. Ortega-Peña & R. González-Cuevas. (2021) Familiar dermatologic drugs as therapies for COVID-19. Actas Dermo-Sifiliográficas (English Edition) 112:2, pages 118-126.
Crossref
Crossref
M. Ortega-Peña & R. González-Cuevas. (2021) Fármacos de uso frecuente en dermatología como terapia para COVID-19. Actas Dermo-Sifiliográficas 112:2, pages 118-126.
Crossref
Crossref
Kavita Manchanda, Jasbir Singh, Ranjeev Bhagat, Ilmjot Kaur Tiwana & Harmanjit Singh. (2021) Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective. International Journal of Risk & Safety in Medicine 32:1, pages 3-17.
Crossref
Crossref
Padmaja Udaykumar, Bhavya Shetty & Anurag Kundapur. (2021) Drug interactions of ivermectin with a focus on COVID-19 treatment. Muller Journal of Medical Sciences and Research 12:1, pages 42.
Crossref
Crossref
Mennat-Elrahman Ahmed Fahmy, Amany Ahmed Abdelaal, Soad Ismail Hassan, Maisa Ahmed Shalaby, Mousa Abdelgawad Mousa Ismail, Rasha Ahmed Khairy, Manal Abdelmaged Badawi, Adam Ashraf Afife & Hanaa Omar Fadl. (2021) Antiparasitic and immunomodulating effects of nitazoxanide, ivermectin and selenium on Cryptosporidium infection in diabetic mice. Revista Brasileira de Parasitologia Veterinária 30:4.
Crossref
Crossref
Marcos Luciano Pimenta PINHEIRO, Ricardo Lopes ROCHA & Melissa Monteiro GUIMARÃES. (2021) Is chemoprophylaxis with ivermectin in dentistry effective at preventing COVID-19?. RGO - Revista Gaúcha de Odontologia 69.
Crossref
Crossref
Niti Mittal & Rakesh Mittal. (2021) Inhaled route and anti-inflammatory action of ivermectin: Do they hold promise in fighting against COVID-19?. Medical Hypotheses 146, pages 110364.
Crossref
Crossref
Quinton J. Tafoya. 2021. Neurological Care and the COVID-19 Pandemic. Neurological Care and the COVID-19 Pandemic
171
179
.
Sanjay Pandey, Subodh Kumar Pathak, Apurva Pandey, Abhijeet Ashok Salunke, Jasneet Chawla, Aryan Sharma, Sarthak Sharma, Praveen Thivari & Harish V.K. Ratna. (2020) Ivermectin in COVID-19: What do we know?. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14:6, pages 1921-1922.
Crossref
Crossref
Coralie Valle, Baptiste Martin, Franck Touret, Ashleigh Shannon, Bruno Canard, Jean‐Claude Guillemot, Bruno Coutard & Etienne Decroly. (2020)
Drugs against
SARS‐CoV
‐2: What do we know about their mode of action?
. Reviews in Medical Virology 30:6, pages 1-10.
Crossref
Crossref
Sareh Zhand, Marie Saghaeian Jazi, Saeed Mohammadi, Roozbeh Tarighati Rasekhi, Ghassem Rostamian, Mohammad Reza Kalani, Aida Rostamian, Jacob George & Mark W Douglas. (2020) COVID-19: The Immune Responses and Clinical Therapy Candidates. International Journal of Molecular Sciences 21:15, pages 5559.
Crossref
Crossref
Juan Chamie-Quintero, Jennifer Hibberd & David Scheim. (2021) Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments. SSRN Electronic Journal.
Crossref
Crossref
David Scheim. (2020) From Cold to Killer: How SARS-CoV-2 Evolved without Hemagglutinin Esterase to Agglutinate, Then Clot Blood Cells in Pulmonary and Systemic Microvasculature. SSRN Electronic Journal.
Crossref
Crossref